Advancements in Cancer Treatment: A Comprehensive Look at Targeted Injections and Immunotherapies
Over the past few years, there has been remarkable progress in cancer treatment, focusing more on the target therapies and immunotherapies. These advancements have significantly improved outcomes for several cancer patients, underscoring the pivotal role of these precise treatments in modern oncology. This article explores the cutting-edge progress in cancer care, focusing specifically on the impact and advancements of targeted injections and immunotherapies. Targeted Injections Trastuzumab (Herceptin) One of the examples of targeted therapy is Trastuzumab, otherwise known as Herceptin. This monoclonal antibody treats HER2-positive breast cancer. By specifically targeting the HER2 protein, Herceptin interferes with the growth of cancer cells, which helps to improve outcomes and survival rates of the patients. Bevacizumab (Avastin) Bevacizumab (Avastin), an angiogenesis inhibitor, represents another breakthrough in cancer treatment. They block the new blood vessels that feed tumors, i...